You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

emicizumab

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bleeding Rates Among Severe Hemophilia A on Emicizumab

Not yet recruiting
  • Hemophilia A
  • Emicizumab
  • Newark, New Jersey
    Newark Beth Israel Medical Center
Oct 26, 2023

Hemophilia A Trial (Fitusiran (SAR439774), Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin

Not yet recruiting
  • Hemophilia A
  • Fitusiran (SAR439774)
  • +3 more
  • (no location specified)
Nov 17, 2023

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Trial in Peoria (Emicizumab)

Not yet recruiting
  • Von Willebrand Disease, Type 3
  • Concomitant VWD and Hemophilia
  • Emicizumab
  • Peoria, Illinois
    Bleeding and Clotting Disorders Institute
Aug 12, 2022

Bleeding in Moderate and Severe Hemophilia A Playing Sports: A

Not yet recruiting
  • Hemophilia A
  • (no location specified)
Mar 4, 2022

Acquired Hemophilia A Trial in Seattle (emicizumab)

Not yet recruiting
  • Acquired Hemophilia A
  • emicizumab
  • Seattle, Washington
    Washington Center for Bleeding Disorders
Apr 22, 2022

Hemophilia A, Immune Tolerance Trial in Los Angeles (FVIII, Emicizumab)

Active, not recruiting
  • Hemophilia A
  • Immune Tolerance
  • Los Angeles, California
    Childrens Hospital Los Angeles
Mar 7, 2022

Hemophilia A Trial in Worldwide (Emicizumab)

Active, not recruiting
  • Hemophilia A
  • Emicizumab
  • Beijing City, China
  • +12 more
Nov 21, 2022

Hemophilia A With Inhibitor Trial in Pittsburgh (Eloctate ITI, Emicizumab)

Terminated
  • Hemophilia A With Inhibitor
  • Eloctate ITI
  • Emicizumab
  • Pittsburgh, Pennsylvania
  • +1 more
Jul 6, 2022

Hemophilia A Trial in Worldwide (Emicizumab)

Completed
Has Results
  • Hemophilia A
  • Emicizumab
  • Sacramento, California
  • +16 more
Dec 13, 2022

Severe Hemophilia A, Moderate Hemophilia A Trial in Worldwide (Emicizumab)

Recruiting
  • Severe Hemophilia A
  • Moderate Hemophilia A
  • Emicizumab
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Factor VIII Deficiency, Congenital Trial in Indianapolis (Emicizumab)

Recruiting
  • Factor VIII Deficiency, Congenital
  • Emicizumab
  • Indianapolis, Indiana
    Indiana Hemophila @Thrombosis Center
Oct 6, 2021

Hemophilia A Trial in United States (Emicizumab)

Terminated
Has Results
  • Hemophilia A
  • Emicizumab
  • Los Angeles, California
  • +7 more
Feb 9, 2021

Hemophilia A Trial in Worldwide (Emicizumab)

Completed
Has Results
  • Hemophilia A
  • Emicizumab
  • Los Angeles, California
  • +27 more
May 7, 2021

Hemophilia A Trial in Worldwide (Emicizumab, rFVIIa, aPCC)

Completed
Has Results
  • Hemophilia A
  • Emicizumab
  • +2 more
  • Los Angeles, California
  • +43 more
May 26, 2021

Hemophilia A Trial in Worldwide (Emicizumab)

Completed
Has Results
  • Hemophilia A
  • Emicizumab
  • Camperdown, New South Wales, Australia
  • +71 more
May 17, 2021

Healthy Volunteers, Hemophilia A Trial in Beijing (Emicizumab)

Completed
Has Results
  • Healthy Volunteers
  • Hemophilia A
  • Emicizumab
  • Beijing, China
    Peking University Third Hospital
Sep 3, 2019